| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
MicroRNA expression, survival, and response to interferon in liver cancer.
|
N Engl J Med
|
2009
|
6.13
|
|
2
|
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
|
Gastroenterology
|
2008
|
5.53
|
|
3
|
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.
|
Nat Med
|
2003
|
5.45
|
|
4
|
Randomized controlled trial of screening for hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2004
|
5.29
|
|
5
|
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
|
J Clin Oncol
|
2007
|
5.28
|
|
6
|
Identification of metastasis-related microRNAs in hepatocellular carcinoma.
|
Hepatology
|
2008
|
4.50
|
|
7
|
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.
|
Cancer Cell
|
2006
|
4.33
|
|
8
|
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
|
Cancer Res
|
2008
|
4.17
|
|
9
|
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells.
|
Hepatology
|
2009
|
3.92
|
|
10
|
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
|
J Clin Oncol
|
2008
|
2.92
|
|
11
|
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.
|
Cancer Res
|
2010
|
2.59
|
|
12
|
The prognostic molecular markers in hepatocellular carcinoma.
|
World J Gastroenterol
|
2002
|
2.47
|
|
13
|
Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis.
|
World J Gastroenterol
|
2003
|
2.07
|
|
14
|
The prognostic significance of clinical and pathological features in hepatocellular carcinoma.
|
World J Gastroenterol
|
2002
|
2.03
|
|
15
|
Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
|
J Hepatol
|
2007
|
1.86
|
|
16
|
Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics.
|
J Cancer Res Clin Oncol
|
2004
|
1.86
|
|
17
|
A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma.
|
Cancer J
|
2004
|
1.84
|
|
18
|
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
|
J Cancer Res Clin Oncol
|
2004
|
1.75
|
|
19
|
Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.
|
Clin Cancer Res
|
2007
|
1.73
|
|
20
|
Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.
|
Clin Cancer Res
|
2010
|
1.72
|
|
21
|
Diagnosis and treatment of hepatic angiomyolipoma in 26 cases.
|
World J Gastroenterol
|
2003
|
1.71
|
|
22
|
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
|
Gastroenterology
|
2011
|
1.68
|
|
23
|
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.66
|
|
24
|
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
|
Cancer J
|
2006
|
1.65
|
|
25
|
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.
|
J Cancer Res Clin Oncol
|
2006
|
1.60
|
|
26
|
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.
|
Hepatology
|
2012
|
1.57
|
|
27
|
Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
|
Clin Cancer Res
|
2006
|
1.46
|
|
28
|
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
|
Clin Cancer Res
|
2011
|
1.46
|
|
29
|
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.
|
Mol Cell Proteomics
|
2003
|
1.45
|
|
30
|
Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
|
Clin Cancer Res
|
2009
|
1.43
|
|
31
|
Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma.
|
J Hepatol
|
2010
|
1.41
|
|
32
|
Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
|
Clin Cancer Res
|
2008
|
1.40
|
|
33
|
Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
|
Cancer
|
2009
|
1.37
|
|
34
|
Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis.
|
Proteomics
|
2005
|
1.33
|
|
35
|
Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
|
Clin Cancer Res
|
2010
|
1.31
|
|
36
|
Hepatocellular carcinoma: insight from animal models.
|
Nat Rev Gastroenterol Hepatol
|
2011
|
1.28
|
|
37
|
Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.
|
Gastroenterology
|
2010
|
1.28
|
|
38
|
Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes.
|
Gastroenterology
|
2013
|
1.27
|
|
39
|
Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients.
|
World J Gastroenterol
|
2004
|
1.27
|
|
40
|
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma.
|
Jpn J Clin Oncol
|
2005
|
1.25
|
|
41
|
Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
|
Clin Cancer Res
|
2011
|
1.24
|
|
42
|
Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
|
Clin Cancer Res
|
2005
|
1.19
|
|
43
|
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials.
|
Proteomics
|
2004
|
1.19
|
|
44
|
MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.
|
Carcinogenesis
|
2013
|
1.19
|
|
45
|
Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
|
Ann Surg Oncol
|
2011
|
1.17
|
|
46
|
Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
|
BMC Cancer
|
2009
|
1.16
|
|
47
|
Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.15
|
|
48
|
The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2006
|
1.14
|
|
49
|
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
|
Clin Cancer Res
|
2008
|
1.13
|
|
50
|
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives.
|
J Cancer Res Clin Oncol
|
2004
|
1.12
|
|
51
|
MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.
|
PLoS One
|
2013
|
1.12
|
|
52
|
Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy.
|
J Surg Oncol
|
2007
|
1.12
|
|
53
|
Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
|
Gastroenterology
|
2012
|
1.11
|
|
54
|
P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma.
|
Cancer
|
2006
|
1.11
|
|
55
|
Hepatic angiomyolipoma: a retrospective study of 25 cases.
|
Surg Today
|
2008
|
1.11
|
|
56
|
Relationship between expression of alpha-fetoprotein messenger RNA and some clinical parameters of human hepatocellular carcinoma.
|
World J Gastroenterol
|
1999
|
1.10
|
|
57
|
The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
|
PLoS One
|
2013
|
1.09
|
|
58
|
Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.
|
World J Gastroenterol
|
2003
|
1.09
|
|
59
|
Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients.
|
World J Surg
|
2012
|
1.09
|
|
60
|
Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.
|
Clin Cancer Res
|
2013
|
1.09
|
|
61
|
Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice.
|
Eur J Gastroenterol Hepatol
|
2008
|
1.09
|
|
62
|
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure.
|
Mutat Res
|
2008
|
1.08
|
|
63
|
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients.
|
BMC Cancer
|
2010
|
1.08
|
|
64
|
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection.
|
Oncologist
|
2008
|
1.08
|
|
65
|
HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.
|
Cancer
|
2011
|
1.06
|
|
66
|
Focal nodular hyperplasia of the liver in 86 patients.
|
Hepatobiliary Pancreat Dis Int
|
2007
|
1.06
|
|
67
|
Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.
|
Am J Clin Pathol
|
2009
|
1.06
|
|
68
|
Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin.
|
BMC Cancer
|
2010
|
1.03
|
|
69
|
P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.
|
World J Gastroenterol
|
2002
|
1.02
|
|
70
|
Dendritic cell infiltration and prognosis of human hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2006
|
1.02
|
|
71
|
Hepatocellular carcinoma surgery--review of the past and prospects for the 21st century.
|
J Surg Oncol
|
2005
|
1.02
|
|
72
|
Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.
|
World J Gastroenterol
|
2004
|
1.01
|
|
73
|
Herbal extract "Songyou Yin" inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential.
|
J Cancer Res Clin Oncol
|
2009
|
1.01
|
|
74
|
Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.
|
PLoS One
|
2013
|
1.00
|
|
75
|
Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice.
|
J Gastrointest Surg
|
2003
|
1.00
|
|
76
|
Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor.
|
Cancer
|
2008
|
1.00
|
|
77
|
Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis.
|
World J Gastroenterol
|
2005
|
0.99
|
|
78
|
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasms.
|
Clin Gastroenterol Hepatol
|
2009
|
0.99
|
|
79
|
Experimental models of hepatocellular carcinoma: developments and evolution.
|
J Cancer Res Clin Oncol
|
2009
|
0.98
|
|
80
|
Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential.
|
J Cancer Res Clin Oncol
|
2004
|
0.98
|
|
81
|
Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma.
|
PLoS One
|
2013
|
0.97
|
|
82
|
Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
|
Liver Int
|
2013
|
0.96
|
|
83
|
Serum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.
|
World J Gastroenterol
|
2000
|
0.96
|
|
84
|
The biocompatibility of quantum dot probes used for the targeted imaging of hepatocellular carcinoma metastasis.
|
Biomaterials
|
2008
|
0.96
|
|
85
|
Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.
|
J Cancer Res Clin Oncol
|
2004
|
0.96
|
|
86
|
An immune function assay predicts post-transplant recurrence in patients with hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2011
|
0.96
|
|
87
|
Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2009
|
0.96
|
|
88
|
Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma.
|
Int J Cancer
|
2011
|
0.95
|
|
89
|
Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2008
|
0.95
|
|
90
|
Impact factors for microinvasion in patients with hepatocellular carcinoma: possible application to the definition of clinical tumor volume.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.95
|
|
91
|
Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma.
|
Cancer Sci
|
2009
|
0.94
|
|
92
|
Study of angiogenesis induced by metastatic and non-metastatic liver cancer by corneal micropocket model in nude mice.
|
World J Gastroenterol
|
1999
|
0.94
|
|
93
|
The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib.
|
Oncotarget
|
2014
|
0.93
|
|
94
|
Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma.
|
PLoS One
|
2013
|
0.93
|
|
95
|
Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues.
|
J Cancer Res Clin Oncol
|
2005
|
0.93
|
|
96
|
Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.
|
Oncologist
|
2011
|
0.93
|
|
97
|
The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
|
Mol Biol Rep
|
2011
|
0.92
|
|
98
|
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2006
|
0.92
|
|
99
|
Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation.
|
J Gastroenterol
|
2009
|
0.92
|
|
100
|
Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma.
|
BMC Cancer
|
2007
|
0.91
|
|
101
|
Modulation of miR-29 expression by α-fetoprotein is linked to the hepatocellular carcinoma epigenome.
|
Hepatology
|
2014
|
0.91
|
|
102
|
High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery.
|
Cancer
|
2012
|
0.91
|
|
103
|
Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.
|
J Cancer Res Clin Oncol
|
2003
|
0.91
|
|
104
|
The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer.
|
World J Gastroenterol
|
2000
|
0.91
|
|
105
|
Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
|
J Cancer Res Clin Oncol
|
2008
|
0.90
|
|
106
|
Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: relevance of epithelial-mesenchymal transition.
|
Cancer Sci
|
2009
|
0.90
|
|
107
|
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.
|
Oncologist
|
2010
|
0.90
|
|
108
|
Surgery for large primary liver cancer more than 10 cm in diameter.
|
J Cancer Res Clin Oncol
|
2003
|
0.90
|
|
109
|
Prognostic analysis of pulmonary metastases from hepatocellular carcinoma.
|
Hepatol Int
|
2008
|
0.90
|
|
110
|
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy.
|
Cancer Sci
|
2008
|
0.89
|
|
111
|
DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.
|
World J Gastroenterol
|
2002
|
0.89
|
|
112
|
Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization.
|
J Hematol Oncol
|
2012
|
0.89
|
|
113
|
Molecular cytogenetic characteristics of the human hepatocellular carcinoma cell line HCCLM3 with high metastatic potential: comparative genomic hybridization and multiplex fluorescence in situ hybridization.
|
Cancer Genet Cytogenet
|
2005
|
0.89
|
|
114
|
Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.
|
J Cancer Res Clin Oncol
|
2004
|
0.88
|
|
115
|
Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases.
|
Hepatogastroenterology
|
2006
|
0.88
|
|
116
|
Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
|
BMC Cancer
|
2011
|
0.87
|
|
117
|
Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.
|
Cancer Lett
|
2009
|
0.87
|
|
118
|
Transmembrane receptor CXCR7 increases the risk of extrahepatic metastasis of relatively well-differentiated hepatocellular carcinoma through upregulation of osteopontin.
|
Oncol Rep
|
2013
|
0.86
|
|
119
|
Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience.
|
World J Gastroenterol
|
2006
|
0.86
|
|
120
|
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
|
Angiogenesis
|
2013
|
0.86
|
|
121
|
Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.
|
World J Gastroenterol
|
2008
|
0.86
|
|
122
|
Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection.
|
PLoS One
|
2012
|
0.86
|
|
123
|
Down-regulation of CXCR7 inhibits the growth and lung metastasis of human hepatocellular carcinoma cells with highly metastatic potential.
|
Exp Ther Med
|
2011
|
0.85
|
|
124
|
Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.
|
Mol Biol Rep
|
2010
|
0.85
|
|
125
|
Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue.
|
Int J Cancer
|
2010
|
0.85
|
|
126
|
Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
|
Proteomics
|
2006
|
0.85
|
|
127
|
Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2010
|
0.85
|
|
128
|
Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
|
Eur J Nucl Med Mol Imaging
|
2002
|
0.85
|
|
129
|
KIAA0008 gene is associated with invasive phenotype of human hepatocellular carcinoma--a functional analysis.
|
J Cancer Res Clin Oncol
|
2004
|
0.85
|
|
130
|
Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.
|
J Cancer Res Clin Oncol
|
2003
|
0.84
|
|
131
|
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice.
|
Invest New Drugs
|
2010
|
0.84
|
|
132
|
Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trial.
|
Hepatogastroenterology
|
2004
|
0.84
|
|
133
|
Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases.
|
J Cancer Res Clin Oncol
|
2009
|
0.83
|
|
134
|
Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma.
|
Clin Cancer Res
|
2007
|
0.83
|
|
135
|
Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases.
|
J Cancer Res Clin Oncol
|
2010
|
0.83
|
|
136
|
Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma.
|
World J Gastroenterol
|
2002
|
0.83
|
|
137
|
Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
|
Mol Biol Rep
|
2011
|
0.83
|
|
138
|
Risk factors for postoperative complications after liver resection.
|
Hepatobiliary Pancreat Dis Int
|
2005
|
0.83
|
|
139
|
Herbal compound "Songyou Yin" reinforced the ability of interferon-alfa to inhibit the enhanced metastatic potential induced by palliative resection of hepatocellular carcinoma in nude mice.
|
BMC Cancer
|
2010
|
0.82
|
|
140
|
Direct transformation of lung microenvironment by interferon-α treatment counteracts growth of lung metastasis of hepatocellular carcinoma.
|
PLoS One
|
2013
|
0.82
|
|
141
|
Herbal compound "Songyou Yin" attenuates hepatoma cell invasiveness and metastasis through downregulation of cytokines secreted by activated hepatic stellate cells.
|
BMC Complement Altern Med
|
2013
|
0.82
|
|
142
|
Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.
|
PLoS One
|
2013
|
0.82
|
|
143
|
Hepatocellular carcinoma with situs inversus totalis and polysplenia syndrome.
|
Liver Int
|
2007
|
0.81
|
|
144
|
Capecitabine inhibits postoperative recurrence and metastasis after liver cancer resection in nude mice with relation to the expression of platelet-derived endothelial cell growth factor.
|
Clin Cancer Res
|
2003
|
0.81
|
|
145
|
Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.81
|
|
146
|
A clinicopathological model to predict bone metastasis in hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2011
|
0.80
|
|
147
|
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.
|
PLoS One
|
2011
|
0.80
|
|
148
|
Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness.
|
Evid Based Complement Alternat Med
|
2012
|
0.80
|
|
149
|
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins.
|
J Cancer Res Clin Oncol
|
2004
|
0.80
|
|
150
|
Down-regulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study.
|
J Cancer Res Clin Oncol
|
2007
|
0.80
|
|
151
|
Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection.
|
J Cancer Res Clin Oncol
|
2010
|
0.80
|
|
152
|
Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2007
|
0.79
|
|
153
|
Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
|
Oncology
|
2004
|
0.79
|
|
154
|
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
|
J Cancer Res Clin Oncol
|
2010
|
0.79
|
|
155
|
Regenerative capacity of normal and irradiated liver following partial hepatectomy in rats.
|
Int J Radiat Biol
|
2009
|
0.79
|
|
156
|
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.
|
World J Gastroenterol
|
2006
|
0.79
|
|
157
|
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
|
Int J Cancer
|
2011
|
0.79
|
|
158
|
Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines.
|
World J Gastroenterol
|
2003
|
0.79
|
|
159
|
Abdominal drainage was unnecessary after hepatectomy using the conventional clamp crushing technique.
|
J Gastrointest Surg
|
2006
|
0.78
|
|
160
|
Transfection of thymidine phosphorylase cDNA to human hepatocellular carcinoma cells enhances sensitivity to fluoropyrimidine but augments endothelial cell migration.
|
J Cancer Res Clin Oncol
|
2005
|
0.78
|
|
161
|
Tumor radioimmunoimaging of chimeric antibody in nude mice with hepatoma xenograft.
|
World J Gastroenterol
|
1998
|
0.78
|
|
162
|
Development of a miR-26 companion diagnostic test for adjuvant interferon-alpha therapy in hepatocellular carcinoma.
|
Int J Biol Sci
|
2013
|
0.78
|
|
163
|
Hepatocellular carcinoma associated with tumor thrombosis in the portal vein: the effects of different treatments.
|
Hepatobiliary Pancreat Dis Int
|
2003
|
0.77
|
|
164
|
Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
|
Hepatogastroenterology
|
2003
|
0.77
|
|
165
|
Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients.
|
J Cancer Res Clin Oncol
|
2006
|
0.77
|
|
166
|
[Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
|
Zhonghua Gan Zang Bing Za Zhi
|
2007
|
0.77
|
|
167
|
The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2009
|
0.77
|
|
168
|
Changed clinical aspects of primary liver cancer in China during the past 30 years.
|
Hepatobiliary Pancreat Dis Int
|
2004
|
0.77
|
|
169
|
A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis.
|
Cancer Lett
|
2006
|
0.77
|
|
170
|
Up-regulation of platelet-derived growth factor-A is responsible for the failure of re-initiated interferon alpha treatment in hepatocellular carcinoma.
|
BMC Cancer
|
2012
|
0.77
|
|
171
|
The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential.
|
J Cancer Res Clin Oncol
|
2003
|
0.77
|
|
172
|
Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
|
BMC Cancer
|
2011
|
0.77
|
|
173
|
Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.
|
J Cancer Res Clin Oncol
|
2004
|
0.77
|
|
174
|
The prognostic factor for outcome following second resection for intrahepatic recurrence of hepatocellular carcinoma with a hepatitis B virus infection background.
|
J Cancer Res Clin Oncol
|
2005
|
0.77
|
|
175
|
[Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
|
Zhonghua Yi Xue Za Zhi
|
2005
|
0.76
|
|
176
|
Modulation of gene expression in MHCC97 cells by interferon alpha.
|
World J Gastroenterol
|
2005
|
0.76
|
|
177
|
Caffeine enhances radiosensitization to orthotopic transplant LM3 hepatocellular carcinoma in vivo.
|
Cancer Sci
|
2010
|
0.76
|
|
178
|
Prediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases.
|
Front Oncol
|
2011
|
0.76
|
|
179
|
The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F.
|
World J Gastroenterol
|
2003
|
0.76
|
|
180
|
Atypical hepatic focal nodular hyperplasia presenting as acute abdomen and misdiagnosed as hepatocellular carcinoma.
|
Hepatol Res
|
2007
|
0.76
|
|
181
|
Expert consensus on local ablation therapies for primary liver cancer.
|
Chin Clin Oncol
|
2012
|
0.75
|
|
182
|
[Experimental observation on the alteration of metastatic potential and its gene function net of residual hepatocellular carcinoma following palliative liver resection].
|
Zhonghua Yi Xue Za Zhi
|
2010
|
0.75
|
|
183
|
Liver transplantation: a simple inflammation marker predicts liver cancer prognosis.
|
Nat Rev Gastroenterol Hepatol
|
2011
|
0.75
|
|
184
|
[Quantitative analysis of expression of TEY1 gene in liver cancer cells with different metastatic potential].
|
Ai Zheng
|
2003
|
0.75
|
|
185
|
Study on the inhibitory effect of tyroserleutide on tumor growth and metastasis in nude mice model of human hepatocellular carcinoma metastasis.
|
Hepatogastroenterology
|
2007
|
0.75
|
|
186
|
Cryohepatectomy for hepatocellular carcinoma--results in 84 patients.
|
Asian J Surg
|
2002
|
0.75
|
|
187
|
[Migration and invasion of human hepatocellular carcinoma mediated by lung extracts].
|
Ai Zheng
|
2004
|
0.75
|
|
188
|
[Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
|
Ai Zheng
|
2004
|
0.75
|